ESINQ yields 2000000.00% · JNJ yields 2.13%● Live data
📍 ESINQ pulled ahead of the other in Year 1
Combined, ESINQ + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ESINQ + JNJ for your $10,000?
ITT Educational Services, Inc. provides postsecondary degree programs in the United States. It offers master, bachelor, and associate degree programs to approximately 45,000 students; and short-term information technology and business learning solutions for career advancers and other professionals. The company's business education programs include accounting, business administration, financial services, manufacturing, marketing and advertising, and sales; and drafting and design programs consist of architectural and construction drafting, civil drafting, computer aided drafting, electrical and electronics drafting, industrial engineering technology, interior design, landscape architecture, mechanical drafting, and multimedia communications. Its electronics technology programs include communications, computer technology, electronics product design and fabrication, industrial electronics, instrumentation, and telecommunications; and criminal justice programs include corrections, cyber security, investigations, and security and policing. The company's IT programs include communications, network administration, network technology, software development, systems technology, and technical support; and Breckinridge school of nursing and health sciences programs comprise health information technology, medical assisting and administration, and nursing. As of December 31, 2015, it had 138 college locations in 39 states. The company was founded in 1946 and is headquartered in Carmel, Indiana. On September 16, 2016, ITT Educational Services Inc. along with its affiliates filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Southern District of Indiana.
Full ESINQ Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.